FADS7 Antibodies

Santa Cruz Biotechnology provides a broad selection of FADS7 monoclonal antibodies for research in lipid metabolism and fatty acid synthesis. FADS7 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FADS7, or fatty acid desaturase 7, plays a crucial role in the biosynthesis of polyunsaturated fatty acids, which are essential for maintaining cellular function and membrane integrity. FADS7 significantly impacts cardiovascular health and inflammatory responses by influencing the composition of fatty acids in cell membranes. Research focused on FADS7 can reveal important insights into metabolic disorders and potential therapeutic targets. Scientists studying FADS7 can explore its role in various biological pathways and cellular processes. Understanding FADS7 regulation helps illuminate the complexities of lipid metabolism and its impact on human health. Investigating FADS7 expression patterns provides valuable information about tissue-specific functions and regulatory mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of lipid biochemistry and its implications in health and disease.